fingolimod hydrochloride has been researched along with Thrombocytopenia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brait, VH; Chamorro, A; Gallizioli, M; Justicia, C; Meissner, A; MirĂ³-Mur, F; Planas, AM; Salas-Perdomo, A; Urra, X | 1 |
1 other study(ies) available for fingolimod hydrochloride and Thrombocytopenia
Article | Year |
---|---|
Role of the S1P pathway and inhibition by fingolimod in preventing hemorrhagic transformation after stroke.
Topics: Animals; Brain; Brain Ischemia; Fingolimod Hydrochloride; Hemoglobins; Hemorrhage; Lymphocytes; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myeloid Cells; Reperfusion Injury; RNA, Messenger; Sphingosine; Sphingosine 1 Phosphate Receptor Modulators; Sphingosine-1-Phosphate Receptors; Stroke; T-Lymphocytes; Thrombocytopenia; Up-Regulation | 2019 |